Search results
Results from the WOW.Com Content Network
The blood–brain barrier ( BBB) is a highly selective semipermeable border of endothelial cells that regulates the transfer of solutes and chemicals between the circulatory system and the central nervous system, thus protecting the brain from harmful or unwanted substances in the blood. [ 1] The blood–brain barrier is formed by endothelial ...
Distribution (pharmacology) Distribution in pharmacology is a branch of pharmacokinetics which describes the reversible transfer of a drug from one location to another within the body. Once a drug enters into systemic circulation by absorption or direct administration, it must be distributed into interstitial and intracellular fluids.
Purpose. The blood–brain barrier (BBB) is protected by a network of blood vessels and tissue that shields it from harmful substances. This protection also stops anti-cancer drugs from getting to the brain. To treat brain tumours and other brain related diseases, [2] [3] blood–brain barrier disruption is needed for the anti-cancer drugs to ...
The brain has a powerful ability to keep out blood containing unidentified elements, thanks to a feature known as the blood-brain barrier. Bioengineers believe that they can finally work around ...
Chemoreceptor trigger zone. The chemoreceptor trigger zone ( CTZ) is an area of the medulla oblongata that receives inputs from blood -borne drugs or hormones, and communicates with other structures in the vomiting center to initiate vomiting. The CTZ is located within the area postrema, which is on the floor of the fourth ventricle and is ...
The blood brain barrier (BBB) is the semipermeable membrane lining the vascular network of the brain. More specifically, it is a barrier between blood and interstitial fluid of the brain. It is formed by the tight junctions between endothelial cells, astrocytes, and pericytes in the capillaries. The BBB has high electrical resistance. Some ...
Neuropharmacology is the study of how drugs affect function in the nervous system, and the neural mechanisms through which they influence behavior. [ 1] There are two main branches of neuropharmacology: behavioral and molecular. Behavioral neuropharmacology focuses on the study of how drugs affect human behavior ( neuropsychopharmacology ...
Gabapentin was designed by researchers at Parke-Davis to be an analogue of the neurotransmitter GABA that could more easily cross the blood–brain barrier and was first described in 1975 by Satzinger and Hartenstein. [100] [103] Under the brand name Neurontin, it was first approved in May 1993, for the treatment of epilepsy in the United ...